Caption Management, LLC Alkermes Plc. Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Caption Management, LLC holds 60,326 shares of ALKS stock, worth $1.86 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
60,326
Previous 30,000
101.09%
Holding current value
$1.86 Million
Previous $723,000
133.47%
% of portfolio
0.03%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$583 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$400 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$389 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$282 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.05B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...